PB Fintech / Q1-FY25

POLICYBZR Q1 FY25 earnings call.

A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

PositiveCall date pendingBack to POLICYBZR

Revenue

₹1,000 Cr

verified against source

Revenue YoY

52%

reported change

EBITDA

Pending

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
EBITDA (₹ Cr)PositiveWatchNegative
3 actual records
Actual quarterly EBITDA (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q1 FY24: 23 · Positive source sentimentQ1 FY24Q4 FY24: 324 · Positive source sentimentQ4 FY24Q3 FY26: 199 · Positive source sentimentQ3 FY2632423
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

PB Fintech delivered a strong Q1 FY25 with revenue of approximately INR 1,000 crore (up 52% YoY) and PAT of INR 60 crore, driven by exceptional health and life insurance new business growth of 78% YoY. The core insurance premium grew 46% with core revenues up 40%. Management deliberately over-invested by approximately $3 million (INR 25 crore GST one-off) to build operational capacity ahead of anticipated continued growth, explaining why PAT could have been INR 90 crore otherwise. The renewal ARR stands at INR 559 crore (up from INR 418 crore YoY) with robust trailing metrics. Credit-linked revenue disappointed at INR 130 crore (-8% YoY) versus guidance of 0-10%, with management acknowledging the need to 'repair quite quickly' and pivoting toward secured lending. New initiatives scaled 2.3x with losses contracting from -31% to -12% of revenue. The primary risk is credit business weakness and market share concentration in health/life insurance amid pricing cycle concerns, though management sees the industry as underpenetrated (India health insurance at $10B vs US $800B). Management targets Paisabazaar strategy clarity within 1-2 quarters and shareholder returns evaluation post-March 2026.

Colored figures show movement against the previous available record.

Guidance to track

  • Management explicitly guided that despite Q1 renewal ARR being lower at 34% due to slower new business growth 12 months ago, full-year renewal premium will reach 45-46%, with Q2 at 40+%, improving through the year.
  • Paisabazaar CEO Naveen Kukreja guided that industry unsecured credit recovery will resume in H2 FY25, with secured business expected to grow faster and eventually reach 50% of total disbursements (currently 15%).
  • Chairman Yashish Dahiya indicated the board is rethinking Paisabazaar's direction—potentially pivoting toward secured lending (similar to European fintech remortgage markets)—with clarity expected in 1-2 quarters.
  • Naveen Kukreja guided that personal finance management products leveraging the Account Aggregator framework will pilot in Q2, with loyalty/rewards pilots following in Q3-Q4, with no significant cost impact expected.

Risks flagged

  • Paisabazaar credit-linked revenue declined 8% YoY to INR 130 crore versus management's own guidance of 0-10% growth. The regulator's advisory on unsecured lending has impacted the industry for multiple quarters, and while management expects recovery in H2, there is no guaranteed timeline. Analyst Sachin Salgaonkar explicitly questioned whether the business model needs revisiting.
  • Savings product mix shifted toward lower-margin ULIPs (take rates now ~60% of company average), compressing overall take rates despite growing premium. If ULIP mix continues to increase, revenue may grow slower than premium for an extended period. Management acknowledged 25% of business at 15% margin decline = ~4% overall impact.
  • Management expressed concern that the current healthcare model (focused on revenue per bed) is unsustainable, with room rents of INR 60,000-66,000 making policies unaffordable for the average buyer (INR 6-10 lakh annual income). Unless this model is fixed, price hikes will continue annually and eventually suppress industry growth.
  • Yashish Dahiya stated he has spent 50%+ of his time on hospital/claims integration over six months but admitted no concrete plan is ready. Analyst Srinath directly asked about leveraging 15-20% of retail hospital claims through Policybazaar customers, but management could only commit to 'another quarter' before sharing details. This represents a significant deferred growth opportunity.

Key quotes

  • I believe we are still in the very, very early days of our growth stage. Just to put in perspective, we haven't had growth like this in a very long time, and this is on the core business itself.
  • Our renewal rates have held up. In fact, they are only improving. We don't see that issue. As I explained, our porting is lower than the market. How do I say it in the simplest form? We are the solution, we are not the problem.
  • The sweet spot for us is really 20%-35%, because if you go beyond 50, the founder somehow believes that it's not their company anymore. I think that was where early learning was.

Research modules

Go one layer deeper.